| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_67dd1f39f37bac4617e37d6d5c60aa8b |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 |
| filingDate |
2019-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_142fa88dea235393184b2a3b17b0514a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03bbd56238a276d1dfc93d8c12a8e85d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f05da04396a708289eb8b7e12723c4ca |
| publicationDate |
2020-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2020186182-A |
| titleOfInvention |
Target proteolysis-inducing compound |
| abstract |
PROBLEM TO BE SOLVED: To provide a novel target protein degradation-inducing compound useful as a medicine for preventing or treating a disease caused by dysregulation of protein activity. Equation (I): (In the formula, each symbol is as defined in the specification) The compound represented by or a pharmacologically acceptable salt thereof. [Selection diagram] Fig. 1 |
| priorityDate |
2019-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |